REQUEST A DEMO
Total
USD $0.00
Search more companies

Weleader Biomedical Co. , Ltd. (Taiwan, China)

Main Activities: Surgical and Medical Instrument Manufacturing
Full name: Weleader Biomedical Co. , Ltd. Profile Updated: March 18, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English & Chinese Download a sample report

Weleader Biomedical Co. , Ltd. is an enterprise based in Taiwan, China. Its main office is in Kaohsiung City. The company operates in the Surgical and Medical Instrument Manufacturing industry. The enterprise was incorporated on May 21, 2026. The company’s latest financial report indicates a net sales revenue increase of 11.92% in 2025. Its total assets grew by 22.57% over the same period. Weleader Biomedical Co. , Ltd.’s net profit margin increased by 1.63% in 2025.

Headquarters
19F-1,2,No.80,Minzu 1St Rd.,Sanmin District
Kaohsiung City; Kaohsiung City;

Contact Details: Purchase the Weleader Biomedical Co. , Ltd. report to view the information.

Website: http://www.weleader.com

Basic Information
Financial Auditors:
Purchase the Weleader Biomedical Co. , Ltd. report to view the information.
Incorporation Date:
May 21, 2026
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Chief Financial Officer
Purchase this report to view the information.
General Manager
Ownership Details
Purchase this report to view the information.
12.54%
Purchase this report to view the information.
11.56%
Purchase this report to view the information.
9.9%
Purchase this report to view the information.
9.9%
Purchase this report to view the information.
8.99%
Subsidiaries
優品生醫股份有限公司
100%
Health Leader Biomedical Co.,Ltd
Company Performance
Financial values in the chart are available after Weleader Biomedical Co. , Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency TWD. Absolute financial data is included in the purchased report.
Net sales revenue
11.92%
Total Operating Revenue
11.71%
Operating Profit
21%
EBITDA
18.59%
Net Profit/Loss for the Period
22.53%
Total Assets
22.57%
Total Equity
38.71%
Operating Profit Margin
1.8%
Net Profit Margin
1.63%
Return on Equity (ROE)
-2.19%
Debt / Equity
-19.16%
Quick Ratio
0.48%
Cash Ratio
0.18%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?